ARS Pharmaceuticals, Inc.
SPRY- 交易所
- Nasdaq
- 產業
- Pharmaceutical Preparations
- SEC CIK
- 0001671858
近 90 天，ARS Pharmaceuticals, Inc. 沒有內部人公開市場買賣的申報；2026 年第 2 季末有 208 家機構在 13F 申報持有，市值合計 $7.26 億；大師中只有第三點資本持有。
SEC 申報
ARS Pharmaceuticals, Inc. 向 SEC 申報的 10-K、10-Q、8-K、20-F、40-F，最新的在前。
Livermore 只列出每份申報的表單、8-K 的 Item 與日期。內文請到 SEC 網站讀；8-K 的新聞稿等附件（例如 Item 2.02 的 EX-99.1）在申報目錄裡。
| 申報日 | 表單 | 8-K 的 Item | 期間 | 原文 | 申報目錄 |
|---|---|---|---|---|---|
| 2026/11/5 | 10-Q | – | 2026/9/30 | SEC | 目錄 |
| 2026/11/5 | 8-K | 2.029.01 | 2026/11/5 | SEC | 目錄 |
| 2026/8/13 | 10-Q | – | 2026/6/30 | SEC | 目錄 |
| 2026/8/13 | 8-K | 2.029.01 | 2026/8/13 | SEC | 目錄 |
| 2026/7/17 | 8-K | 5.02 | 2026/7/15 | SEC | 目錄 |
| 2026/7/7 | 8-K | 5.02 | 2026/7/6 | SEC | 目錄 |
| 2026/6/25 | 8-K | 5.07 | 2026/6/24 | SEC | 目錄 |
| 2026/5/15 | 10-Q | – | 2026/3/31 | SEC | 目錄 |
| 2026/5/15 | 8-K | 2.027.019.01 | 2026/5/15 | SEC | 目錄 |
| 2026/5/13 | 8-K | 5.029.01 | 2026/5/12 | SEC | 目錄 |
| 2026/3/9 | 10-K | – | 2025/12/31 | SEC | 目錄 |
| 2026/3/9 | 8-K | 2.027.019.01 | 2026/3/9 | SEC | 目錄 |
| 2025/11/10 | 10-Q | – | 2025/9/30 | SEC | 目錄 |
| 2025/11/10 | 8-K | 2.027.019.01 | 2025/11/10 | SEC | 目錄 |
| 2025/9/29 | 8-K | 1.012.039.01 | 2025/9/29 | SEC | 目錄 |
| 2025/8/28 | 8-K | 8.01 | 2025/8/13 | SEC | 目錄 |
| 2025/8/13 | 10-Q | – | 2025/6/30 | SEC | 目錄 |
| 2025/8/13 | 8-K | 2.027.019.01 | 2025/8/13 | SEC | 目錄 |
| 2025/6/26 | 8-K | 5.07 | 2025/6/25 | SEC | 目錄 |
| 2025/5/14 | 10-Q | – | 2025/3/31 | SEC | 目錄 |
| 2025/5/14 | 8-K | 2.029.01 | 2025/5/14 | SEC | 目錄 |
| 2025/5/2 | 8-K | 1.01 | 2025/5/2 | SEC | 目錄 |
| 2025/3/20 | 10-K | – | 2024/12/31 | SEC | 目錄 |
| 2025/3/20 | 8-K | 2.029.01 | 2025/3/20 | SEC | 目錄 |
| 2025/3/5 | 8-K | 8.01 | 2025/3/5 | SEC | 目錄 |
| 2025/1/13 | 8-K | 2.027.019.01 | 2025/1/13 | SEC | 目錄 |
| 2024/12/6 | 10-Q/A | – | 2024/9/30 | SEC | 目錄 |
| 2024/11/13 | 10-Q | – | 2024/9/30 | SEC | 目錄 |
| 2024/11/13 | 8-K | 2.029.01 | 2024/11/13 | SEC | 目錄 |
| 2024/11/12 | 8-K | 1.01 | 2024/11/9 | SEC | 目錄 |
| 2024/10/15 | 8-K | 1.01 | 2024/10/8 | SEC | 目錄 |
| 2024/9/23 | 8-K | 1.01 | 2024/9/17 | SEC | 目錄 |
| 2024/8/12 | 8-K | 7.018.019.01 | 2024/8/9 | SEC | 目錄 |
| 2024/8/6 | 10-Q | – | 2024/6/30 | SEC | 目錄 |
| 2024/8/6 | 8-K | 2.029.01 | 2024/8/6 | SEC | 目錄 |
| 2024/6/28 | 8-K | 7.019.01 | 2024/6/28 | SEC | 目錄 |
| 2024/6/28 | 8-K | 7.018.019.01 | 2024/6/27 | SEC | 目錄 |
| 2024/6/21 | 8-K | 5.07 | 2024/6/20 | SEC | 目錄 |
| 2024/5/10 | 8-K | 7.019.01 | 2024/5/10 | SEC | 目錄 |
| 2024/5/9 | 10-Q | – | 2024/3/31 | SEC | 目錄 |
| 2024/5/9 | 8-K | 2.029.01 | 2024/5/9 | SEC | 目錄 |
| 2024/3/21 | 10-K | – | 2023/12/31 | SEC | 目錄 |
| 2024/3/21 | 8-K | 2.029.01 | 2024/3/21 | SEC | 目錄 |
| 2024/3/7 | 8-K | 2.027.019.01 | 2024/3/7 | SEC | 目錄 |
| 2023/11/9 | 10-Q | – | 2023/9/30 | SEC | 目錄 |
| 2023/11/9 | 8-K | 2.029.01 | 2023/11/9 | SEC | 目錄 |
| 2023/9/25 | 8-K | 7.019.01 | 2023/9/25 | SEC | 目錄 |
| 2023/9/20 | 8-K | 8.01 | 2023/9/19 | SEC | 目錄 |
| 2023/8/10 | 10-Q | – | 2023/6/30 | SEC | 目錄 |
| 2023/8/10 | 8-K | 2.029.01 | 2023/8/10 | SEC | 目錄 |